Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
29 studies found for:    IL12B
Show Display Options
Rank Status Study
1 Completed Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.
Condition: Crohn Disease
Interventions: Drug: ABBV-066;   Drug: Placebo
2 Completed
Has Results
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Ustekinumab 90 mg;   Drug: Ustekinumab 4.5 mg/kg;   Drug: Placebo SC;   Drug: Placebo IV
3 Completed
Has Results
A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg
4 Completed
Has Results
A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: CNTO 1275
5 Completed
Has Results
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
Condition: Arthritis, Psoriatic
Interventions: Drug: placebo;   Drug: ustekinumab 45 mg;   Drug: ustekinumab 90 mg
6 Recruiting Confirmatory Study of DSP-5423P in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: DSP-5423P 40mg;   Drug: DSP-5423P 80mg;   Drug: DSP-5423P Placebo
7 Unknown  Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
Conditions: Breast Cancer;   Colorectal Cancer;   Melanoma (Skin)
Interventions: Biological: Corynebacterium granulosum P40;   Procedure: adjuvant therapy
8 Completed
Has Results
Safety and Efficacy of the Addition of 0.3% Lidocaine With EVOLENCE®
Conditions: Aging;   Pain
Interventions: Device: Evolence;   Device: Lidocaine;   Drug: topical anesthetic
9 Completed Exhaled Nitric Oxide and Airway Caliber in Children With Asthma
Condition: Asthma in Children
10 Unknown  Maternal Serum Cytokine Levels and Angiogenic Factor Levels in IVF vs Spontaneously Conceived Pregnancies
Condition: Infertility
11 Not yet recruiting Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells
Condition: Inflammatory Bowel Disease
Intervention: Biological: Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab
12 Recruiting IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
13 Active, not recruiting Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Ustekinumab;   Other: Placebo
14 Completed Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Cancer Recurrent
Intervention: Radiation: 3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT
15 Completed Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Biological: IL-12
16 Recruiting Ustekinumab for the Treatment of Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Temporal Arteritis;   Horton's Disease
Interventions: Drug: Ustekinumab;   Drug: Prednisone
17 Completed Rituximab for Pulmonary Sarcoidosis
Condition: Sarcoidosis
Intervention: Drug: Rituximab
18 Not yet recruiting Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells
Condition: Innate Immune Responses
Intervention: Biological: Blood Plasmacytoid dendritic cells (pDCs) absolute number
19 Completed
Has Results
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Conditions: Psoriasis-Type Psoriasis;   Plaque-Type Psoriasis
Intervention: Drug: Apremilast
20 Completed
Has Results
Low Dose Naltrexone (LDN) Immune Monitoring
Condition: Fibromyalgia
Intervention: Drug: Low Dose Naltrexone

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.